The most robust evidence yet, now available in the Cochrane Library, suggests that national smoking legislation does reduce the harms of passive smoking, and particularly risks from heart disease.
4 February is World Cancer Day. Read more about Cochrane's partnership with UICC to support evidence-based advocacy for cancer control.
An updated Cochrane Review containing more up-to-date research has found that countries who imposed smoking bans found their populations benefited from reduced exposure to passive smoke, specifically cardiovascular disease.
Since the first national legislation banning indoor smoking in all public places was introduced in 2004 in Ireland, there has been an increase in the number of countries, states, and regions adopting similar smoke-free legislation banning smoking in public places and work places. The main reason for this was to protect non-smokers from the harmful health effects of exposure to second hand smoke. Another reason was to provide a supportive environment for people who want to stop smoking.
Tobacco is the second major cause of mortality in the world, and currently responsible for the death of about one in ten adults worldwide. Measures to control the demand for and supply of tobacco products, as well as to protect public health, have been demanded by the World Health Organization.
Cigarette smoking is identified as one the greatest public health disasters of the 20th century, with over 20 million attributable deaths. The World Health Organization estimates that six million people die every year from tobacco-related diseases; 600,000 from the effects of passive smoking.
A team of Irish researchers funded by the Health Research Board, Ireland included 77 studies from populations of 21 countries around the world into this updated Cochrane Review, including the US, UK, Canada, and Spain. The previous review, originally published in 2010, examined how smoking legislation had reduced smoke in public places; these new included studies look at more robust evidence into the effects of passive smoking, and the associated health risks including heart disease.
Researchers found that of the 44 observational studies which specifically assessed cardiovascular disease, 33 of these studies reported evidence of a significant reduction in heart disease following the introduction of these bans. Researchers also found that the greatest reduction in admissions for heart disease following smoking legislation were identified in populations of non-smokers.
Review author, Professor Cecily Kelleher, from University College, Dublin, said: “The current evidence provides more robust support for the previous conclusions that the introduction of national legislative smoking bans does lead to improved health outcomes through a reduction in second hand smoke exposure for countries and their populations. We now need research on the continued longer-term impact of smoking bans on the health outcomes of specific sub-groups of the population, such as young children, disadvantaged, and minority groups.”
- Press Release in Spanish on Cochrane Iberoamérica
- Blog Post on Wissen Was Wirkt in German
- Blog Post on Evidently Cochrane
- Blogshot image from Cochrane UK
Full citation: Frazer K, Callinan JE, McHugh J, van Baarsel S, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD005992. DOI: 10.1002/14651858.CD005992.pub3.
URL Upon publication: http://doi.wiley.com/10.1002/14651858.CD005992.pub3
Lead Author: Professor Cecily Kelleher: University College Dublin, Health Sciences Centre, Belfield, Dublin 4, Ireland.
Author Contact: Dominic Martella, Media relations at University College Dublin, Belfield, Dublin 4, Ireland: M +353 87 2959118+353 87 2959118: Email: firstname.lastname@example.org
Cochrane is a global independent network of researchers, professionals, patients, carers, and people interested in health. Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews. Cochrane is a not-for-profit organization with collaborators from more than 130 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognized as representing an international gold standard for high quality, trusted information.
Find out more at http://cochrane.org
Follow us on twitter @cochranecollab
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company's website can be accessed at www.wiley.com.
If you would like to request complimentary media access to the contents of The Cochrane Library, please email email@example.com.